Found 0 matching trials
An Open-Label Pilot Study of Sublocade as Treatment for Opiate Use Disorder
PHASE1The proposed study is a 12-week, open-label pilot study of sublocade (exten...
Location
Substance Treatment Research Service (STARS) of Columbia University
SUBLOCADE Rapid Initiation Study
PHASE4This study is to evaluate the safety and tolerability of initiating SUBLOCA...
Location
Hassman Research Institute
Symptom-Inhibited Naloxone Induction (SINI) for Buprenorphine Initiation: A Feasibility Trial
PHASE4The goal of this clinical study is to evaluate a new treatment approach cal...
Location
Hope to Health Research & Innovation Centre
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
PHASE2HIV infection, as well as exposure to opioids (including heroin), are assoc...
Location
University of Pennsylvania
Evaluation of Long-term Buprenorphine Plasma Exposure
N/AThe study objective is to characterise the long-term plasma exposure to bup...
Location
Pathway Healthcare
Virginia Opioid Overdose Treatment InitiatVE
PHASE3This is a Phase 3b, open-label study in patients that present to the ED for...
Location
Virginia Commonwealth University
Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway
PHASE3Persons dependent on opioids like heroin, morphine, or codeine have a high ...
Location
Akershus University Hospital
Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail
PHASE2The proposed study is a Type 1 hybrid effectiveness-implementation trial. I...
Status
Active Not Recruiting
Location
Friends Research Institute
INDV-6001 Multiple-Dose Pharmacokinetic Study
PHASE2This is a multicentre, open-label, multiple dose study of INDV-6001 in adul...
Location
Artemis Institute for Clinical Research
Extended Release Naltrexone for Opioid-Dependent Youth
PHASE4The purpose of this study is to compare 6-month treatment outcomes for 15-2...
Location
Friends Research Institute